Advanced Therapy Medicinal Products, or ATMPs, are advanced therapeutic drugs that are based on cell therapy or gene therapy (sometimes in combination with a medical device - where they are then called a tissue engineered product). The criteria to which a drug must conform to be classified as an ATMP, are defined in Article 17 of Regulation (EC) No 1394/2007 by the European Commission.[1]
References
edit- ^ "Archived copy" (PDF). Archived from the original (PDF) on 2020-09-20. Retrieved 2020-11-01.
{{cite web}}: CS1 maint: archived copy as title (link)
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |